Share on LinkedInShare on LinkedIn

ARTICLE · 26 DECEMBER 2025

Bye-Bye 280E: New Executive Order Concerning Cannabis Rescheduling

In a historic development, on December 18, 2025, President Donald Trump signed an Executive Order entitled "Increasing Medical Marijuana And Cannabidiol Research," directing Attorney General...

United StatesCannabis & Hemp

In a historic development, on December 18, 2025, President Donald Trump signed an Executive Order entitled "Increasing Medical Marijuana And Cannabidiol Research," directing Attorney General Pam Bondi to "take all necessary steps to complete the rulemaking process related to rescheduling marijuana to Schedule III of the CSA." Currently, marijuana is a Schedule I drug under the Controlled Substances Act (CSA). The Drug Enforcement Agency began the rescheduling process under President Biden, but that process was uncompleted when President Biden left office. Yesterday's executive action brings to fruition a years long policy review and reflects the most significant change in federal cannabis law since the passage of the CSA.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from